Biotech Values

[GrthzGd]

Market can solve everything until it can't.

It should not be surprising that a large portion of our economy goes towards medical technology (roughly a third of overall medical costs, from what I've seen) given the huge government subsidies being thrown at the US health care system in the form of tax deductions for medical insurance premiums and research grants.

That being said however, the price of Sovaldi in the US relative to the rest of the world tracks fairly closely the relationship that our high per capita income bears to the lower per capita incomes of citizens in other countries.

There are many arguments to be made for changes to the delivery of medical care in the US. Sovaldi's recent, triumphal entry onto the market, however, seems to argue for the success of our current system rather than against it IMO.